Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Radiometer Medical by Quarter
Radiometer Medical (Blood Gas & Acute Care Analyzers) — Recall Events on openFDA
Danaher Radiometer Medical: 0 in Q3 2026. That is the highest of the 35 quarters on record here.
Latest, Q3 2026
0
Period ended Sep 30, 2026
Change on a year earlier
–
0 in Q3 2025
History
35 quarters
Since Q1 2018
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)
Where the Q3 2026 figure comes from
Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Reported in U.S. FDA openFDA Device Recalls API.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Danaher Radiometer Medical, quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-recalls-radiometer
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.